Balasingam S - Search Results

Year	Number of Results
1983	1
1984	1
1988	1
1995	1
1996	1
1998	1
2003	2
2004	1
2005	2
2006	1
2009	1
2010	1
2011	1
2013	3
2014	2
2015	4
2016	5
2017	1
2018	1
2019	1
2020	2
2021	3
2022	3
2023	2
2024	4

1

Human infection studies: Key considerations for challenge agent development and production.

Balasingam S, Meillon S, Chui C, Mann A, La C, Weller CL, King DF, Smith E. Balasingam S, et al. Wellcome Open Res. 2022 Apr 22;7:140. doi: 10.12688/wellcomeopenres.17869.1. eCollection 2022. Wellcome Open Res. 2022. PMID: 35505774 Free PMC article.

2

Mucosal vaccines for SARS-CoV-2: scientific gaps and opportunities-workshop report.

Knisely JM, Buyon LE, Mandt R, Farkas R, Balasingam S, Bok K, Buchholz UJ, D'Souza MP, Gordon JL, King DFL, Le TT, Leitner WW, Seder RA, Togias A, Tollefsen S, Vaughn DW, Wolfe DN, Taylor KL, Fauci AS. Knisely JM, et al. Among authors: balasingam s. NPJ Vaccines. 2023 Apr 12;8(1):53. doi: 10.1038/s41541-023-00654-6. NPJ Vaccines. 2023. PMID: 37045860 Free PMC article.

3

Advance directives: barriers to completion.

Glick KL, Mackay KM, Balasingam S, Dolan KR, Casper-Isaac S. Glick KL, et al. Among authors: balasingam s. J N Y State Nurses Assoc. 1998 Mar;29(1):4-8. J N Y State Nurses Assoc. 1998. PMID: 9923243 Review.

4

The potential for a controlled human infection platform in Singapore.

Balasingam S, Horby P, Wilder-Smith A. Balasingam S, et al. Singapore Med J. 2014 Sep;55(9):456-61. doi: 10.11622/smedj.2014114. Singapore Med J. 2014. PMID: 25273928 Free PMC article. Review.

5

Randomized controlled trials for influenza drugs and vaccines: a review of controlled human infection studies.

Balasingam S, Wilder-Smith A. Balasingam S, et al. Int J Infect Dis. 2016 Aug;49:18-29. doi: 10.1016/j.ijid.2016.05.013. Epub 2016 May 18. Int J Infect Dis. 2016. PMID: 27208631 Free article. Review.

6

Contrast media induced transient cortical blindness.

Balasingam S, Azman RR, Nazri M. Balasingam S, et al. QJM. 2016 Feb;109(2):121-2. doi: 10.1093/qjmed/hcv121. Epub 2015 Jun 22. QJM. 2016. PMID: 26101228 No abstract available.

7

New antiviral drugs, vaccines and classic public health interventions against SARS coronavirus.

Oxford JS, Balasingam S, Chan C, Catchpole A, Lambkin R. Oxford JS, et al. Among authors: balasingam s. Antivir Chem Chemother. 2005;16(1):13-21. doi: 10.1177/095632020501600102. Antivir Chem Chemother. 2005. PMID: 15739618 Free article. Review.

8

Treatment of epidemic and pandemic influenza with neuraminidase and M2 proton channel inhibitors.

Oxford JS, Bossuyt S, Balasingam S, Mann A, Novelli P, Lambkin R. Oxford JS, et al. Among authors: balasingam s. Clin Microbiol Infect. 2003 Jan;9(1):1-14. doi: 10.1046/j.1469-0691.2003.00564.x. Clin Microbiol Infect. 2003. PMID: 12691538 Free article. Review.

9

Comprehensive Insight into the Mechanism, Material Selection and Performance Evaluation of Supercapatteries.

Balasubramaniam S, Mohanty A, Balasingam SK, Kim SJ, Ramadoss A. Balasubramaniam S, et al. Among authors: balasingam sk. Nanomicro Lett. 2020 Apr 4;12(1):85. doi: 10.1007/s40820-020-0413-7. Nanomicro Lett. 2020. PMID: 34138304 Free PMC article. Review.

10

A new millennium conundrum: how to use a powerful class of influenza anti-neuraminidase drugs (NAIs) in the community.

Oxford J, Balasingam S, Lambkin R. Oxford J, et al. Among authors: balasingam s. J Antimicrob Chemother. 2004 Feb;53(2):133-6. doi: 10.1093/jac/dkh037. Epub 2003 Dec 19. J Antimicrob Chemother. 2004. PMID: 14688047 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

44 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

44 results

Results by year